Market News
Stay updated with the latest market trends, earnings, and economic indicators.
India's IPO pipeline in the second half may touch $40 billion as billion-dollar listings line up: JPMorgan
Abhinav Bharti, Managing Director and Head of India ECM at JPMorgan said the Indian market has sufficient depth to absorb multiple large IPOs simultaneously, while global investor interest remains strong for sizeable IPOs across consumer, consumer tech and healthcare sectors.
Kotak Institutional removes ABB India, Siemens, Cummins India from model portfolio
Kotak Institutional Equities' Sanjeev Prasad prefers private banks over IT and expensive industrial stocks, citing attractive valuations, stable credit growth and the potential for re-rating. He warned that AI-driven pricing pressure makes it difficult to value IT companies and said investors should avoid chasing richly valued capital goods and electrification stocks despite strong long-term themes. Healthcare, hospitality, retail and telecom remain among his preferred sectors.
Tech-Led global selloff, Fed rate fears weigh on Indian equities
Indian stock markets experienced their sharpest single-day drop in nearly a month, mirroring a global tech sell-off. The Nifty 50 and BSE Sensex both fell significantly, influenced by a strong US dollar and profit-taking after recent gains. While pharma and healthcare sectors showed resilience, most others, including metals and IT, declined. Market volatility increased, with analysts watching key support levels closely.
Worst is behind us, markets could hit new highs in 6-12 months: Envision’s Nilesh Shah
Nilesh Shah, Founder of Envision Capital, remains positive on digital platforms, defence, aerospace and consumer discretionary sectors, citing long-term domestic growth drivers. Shah expects stronger earnings, policy reforms and foreign investor participation to support markets, while also identifying opportunities linked to GLP-1 drugs, nutrition products and healthcare themes.
Firm strength in dollar offsets gains in INR made from positive equities and easing oil prices
The Indian rupee depreciated 34 paise to close at 94.67 (provisional) against the US dollar on Monday, weighed down by the strength of the American currency in the overseas market. Rupee witnessed volatility as steady debt and deposit inflows pulled the domestic currency in one way, while the lack of clarity on the Middle East peace deal and a firm dollar pulled it the other way. The Indian stock market, which snapped a five-day winning streak on Friday, rebounded and closed higher on Monday, lifted by gains in technology, healthcare and oil sectors. The mood in the market remained positive amid reports of progress in US-Iran peace talks. Additionally, weak oil prices eased concerns about inflation. The benchmark BSE Sensex closed up by 291.17 points or 0.38% at 77,094.07 after scaling a low of 77,160.67 and a high of 77,325.56 intraday. At the interbank foreign exchange market, the rupee opened at 94.42, registering a decline of 9 paise from its previous close. In intraday trade, ...
Cipla appoints health chief Shivam Puri to lead One India business
Cipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take effect from July 1. Puri currently heads Cipla Health, a role he has held since 2019. His extensive experience in consumer goods and healthcare will now steer Cipla's domestic operations.
Margin play: Why Supertails is doubling down on the lucrative pet healthcare market
With medical services yielding double the margins of retail, the startup is expanding its clinic and pharmacy footprint to anchor itself at the centre of India's formalizing pet economy.
Haleon to invest Rs 2,000 crore to set up first India plant
Haleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fast-growing consumer healthcare market. The plant will produce oral-health products, including Sensodyne. It aims to reach one billion more consumers by 2030, with 300 million in India. The facility will also cater to export markets.
PE wars to billion-dollar IPO dreams, hospital sector is fighting fit
Major private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition highlights strong investor confidence in India's healthcare sector. The industry is entering a new growth phase driven by increasing demand, a shortage of hospital beds, and a rise in specialized medical services.
Engineers India Ltd leads losers in 'A' group
Ganesha Ecosphere Ltd, Central Bank of India, Max Healthcare Institute Ltd and GMR Power & Urban Infra Ltd are among the other losers in the BSE's 'A' group today, 22 May 2026.
Q4 Results LIVE Updates: Sanghvi Movers shares surge over 12%; Jubilant Foodworks down 7%
Q4 Results LIVE Updates: ITC, Aurobindo Pharma, LIC, LG Electronics, Ashoka Buildcon, Bikaji Foods, Datamatics, Engineers India, GMM Pfaudler, Happy Forgings, Honasa Consumer, Ixigo, Nykaa, Page Industries, Ramco Cements, Max Healthcare, Prestige Estates, MTNL, Sun TV, Quick Heal, RCF, WeWork, VA Tech Wabag, are among the companies reporting their earnings today. The street will also react to numbers reported by Whirlpool, Apollo Hospitals, Sammaan Capital, JK Lakshmi Cement, Lenskart, Ola Electric and others. Watch this space for all the LIVE earnings updates.
Apollo Hospitals FY26 profit jumps 34% to Rs 1,942 crore on growth across core businesses
Apollo Hospitals announced robust financial results for the fourth quarter and the full fiscal year 2026. Consolidated revenue and net profit saw significant year-on-year increases. Growth was fueled by its healthcare services, diagnostics, and retail health segments. The company is expanding its bed capacity and focusing on underserved markets.